AbbVie's Humira Gets A U.S. Rival, But Costs Could Stay High
U.S. patients will finally get access to cheaper versions of AbbVie Inc's blockbuster arthritis drug Humira this year, but the cost savings are expected to be limited.
Stay updated with breaking news from Cigna Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. patients will finally get access to cheaper versions of AbbVie Inc's blockbuster arthritis drug Humira this year, but the cost savings are expected to be limited.
The Hekemian Group is expected to present its concept plan for the site, currently owned by Cigna Corp.
By Patrick Wingrove (Reuters) - U.S. patients will finally get access to cheaper versions of AbbVie Inc's blockbuster arthritis drug Humira this year,...
By Patrick Wingrove (Reuters) - U.S. patients will finally get access to cheaper versions of AbbVie Inc's blockbuster arthritis drug Humira this year,...
-CVS Health Corp said on Monday that David Joyner would return to head the U.S. diversified healthcare company's pharmacy services and tapped former Cigna Corp executive Amy Bricker as its chief...